NF1 and cutaneous melanoma: Another option to improve the detection rate of our panel would be to increase the mutation analysis coverage of NF1. Based on ctDNA, just 3% of this cohort had NF1 mutations, which is significantly lower than the TCGA value of 10% for cutaneous melanoma [27,28].